Daniel Chargelegue

1.3k total citations
20 papers, 914 citations indexed

About

Daniel Chargelegue is a scholar working on Molecular Biology, Biotechnology and Immunology. According to data from OpenAlex, Daniel Chargelegue has authored 20 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Biotechnology and 7 papers in Immunology. Recurrent topics in Daniel Chargelegue's work include Transgenic Plants and Applications (8 papers), Respiratory viral infections research (6 papers) and Plant tissue culture and regeneration (6 papers). Daniel Chargelegue is often cited by papers focused on Transgenic Plants and Applications (8 papers), Respiratory viral infections research (6 papers) and Plant tissue culture and regeneration (6 papers). Daniel Chargelegue collaborates with scholars based in United Kingdom, Netherlands and Vietnam. Daniel Chargelegue's co-authors include Julian K‐C., Nicholas D. Vine, Pascal M. W. Drake, Keith L. Wycoff, Mich B. Hein, Thomas Lehner, Patricia Obregón, Craig J. van Dolleweerd, Michael Steward and Alessandra Prada and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Virology.

In The Last Decade

Daniel Chargelegue

20 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Chargelegue United Kingdom 16 558 496 286 158 133 20 914
Manuel Osorio United States 13 321 0.6× 84 0.2× 288 1.0× 16 0.1× 63 0.5× 18 793
Lauren A. Hirao United States 17 398 0.7× 155 0.3× 455 1.6× 18 0.1× 243 1.8× 26 1.1k
Laurel A. Lagenaur United States 13 250 0.4× 75 0.2× 72 0.3× 26 0.2× 99 0.7× 27 627
Zarmina Durrani United Kingdom 12 209 0.4× 202 0.4× 151 0.5× 50 0.3× 72 0.5× 16 587
Maria Cândida M. Mellado Portugal 9 310 0.6× 95 0.2× 169 0.6× 79 0.5× 203 1.5× 10 783
Marie Alix Peyrat France 9 276 0.5× 78 0.2× 490 1.7× 36 0.2× 196 1.5× 9 969
Gabriel Meister United States 12 430 0.8× 101 0.2× 143 0.5× 84 0.5× 113 0.8× 20 659
Rosamund Chapman South Africa 16 267 0.5× 241 0.5× 280 1.0× 28 0.2× 113 0.8× 40 642
Søren M. Madsen Denmark 15 329 0.6× 123 0.2× 70 0.2× 14 0.1× 72 0.5× 20 700
R. Postlethwaite United Kingdom 14 172 0.3× 135 0.3× 76 0.3× 28 0.2× 294 2.2× 24 669

Countries citing papers authored by Daniel Chargelegue

Since Specialization
Citations

This map shows the geographic impact of Daniel Chargelegue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Chargelegue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Chargelegue more than expected).

Fields of papers citing papers by Daniel Chargelegue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Chargelegue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Chargelegue. The network helps show where Daniel Chargelegue may publish in the future.

Co-authorship network of co-authors of Daniel Chargelegue

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Chargelegue. A scholar is included among the top collaborators of Daniel Chargelegue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Chargelegue. Daniel Chargelegue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Obregón, Patricia, Daniel Chargelegue, Pascal M. W. Drake, et al.. (2005). HIV‐1 p24–immunoglobulin fusion molecule: a new strategy for plant‐based protein production. Plant Biotechnology Journal. 4(2). 195–207. 70 indexed citations
2.
Chargelegue, Daniel, Pascal M. W. Drake, Patricia Obregón, et al.. (2005). Highly Immunogenic and Protective Recombinant Vaccine Candidate Expressed in Transgenic Plants. Infection and Immunity. 73(9). 5915–5922. 61 indexed citations
3.
Dolleweerd, Craig J. van, Charles Kelly, Daniel Chargelegue, & Julian K‐C.. (2004). Peptide Mapping of a Novel Discontinuous Epitope of the Major Surface Adhesin from Streptococcus mutans. Journal of Biological Chemistry. 279(21). 22198–22203. 17 indexed citations
4.
K‐C., Julian, Pascal M. W. Drake, Daniel Chargelegue, Patricia Obregón, & Alessandra Prada. (2004). Antibody processing and engineering in plants, and new strategies for vaccine production. Vaccine. 23(15). 1814–1818. 48 indexed citations
5.
Dolleweerd, Craig J. van, Daniel Chargelegue, & Julian K‐C.. (2003). Characterization of the Conformational Epitope of Guy's 13, a Monoclonal Antibody That Prevents Streptococcus mutans Colonization in Humans. Infection and Immunity. 71(2). 754–765. 27 indexed citations
6.
Drake, Pascal M. W., Daniel Chargelegue, Nicholas D. Vine, et al.. (2002). Transgenic plants expressing antibodies: a model for phytoremediation. The FASEB Journal. 16(14). 1855–1860. 19 indexed citations
7.
Chargelegue, Daniel, Patricia Obregón, & Pascal M. W. Drake. (2001). Transgenic plants for vaccine production: expectations and limitations. Trends in Plant Science. 6(11). 495–496. 23 indexed citations
8.
Chargelegue, Daniel, Nicholas D. Vine, Craig J. van Dolleweerd, Pascal M. W. Drake, & Julian K‐C.. (2000). A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Transgenic Research. 9(3). 187–194. 93 indexed citations
9.
10.
11.
12.
K‐C., Julian, Keith L. Wycoff, Nicholas D. Vine, et al.. (1998). Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nature Medicine. 4(5). 601–606. 345 indexed citations
13.
Chargelegue, Daniel, et al.. (1997). Peptide mimics of a conformationally constrained protective epitopes of respiratory syncytial virus fusion protein. Immunology Letters. 57(1-3). 15–17. 6 indexed citations
14.
Atabani, Sowsan, Obeid E. Obeid, Daniel Chargelegue, et al.. (1997). Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection. Journal of Virology. 71(10). 7240–7245. 18 indexed citations
15.
16.
Chargelegue, Daniel, Carolynne Stanley, Carol O’Toole, B T Colvin, & Michael Steward. (1995). The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression. Clinical & Experimental Immunology. 99(2). 175–181. 39 indexed citations
17.
18.
Chargelegue, Daniel, Carol O’Toole, & B T Colvin. (1993). A longitudinal study of the IgG antibody response to HIV-1 pl7gagprotein in HIV-1+ patients with haemophilia: titre and avidity. Clinical & Experimental Immunology. 93(3). 331–336. 17 indexed citations
19.
O’Toole, Carol, Susan M. Graham, Mark W. Lowdell, et al.. (1992). Decline in CTL and Antibody Responses to HIV-1 p17 and p24 Antigens in HIV-1-Infected Hemophiliacs Irrespective of Disease Progression. A 5-Year Follow-up Study. AIDS Research and Human Retroviruses. 8(8). 1361–1368. 7 indexed citations
20.
Chargelegue, Daniel & Carol O’Toole. (1992). Development of a sensitive ELISA for HIV-1 p24 antigen using a fluorogenic substrate for monitoring HIV-1 replication in vitro. Journal of Virological Methods. 38(3). 323–332. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Osorio Breakdown of academic impact, for papers by Lauren A. Hirao Breakdown of academic impact, for papers by Laurel A. Lagenaur Breakdown of academic impact, for papers by Zarmina Durrani Breakdown of academic impact, for papers by Maria Cândida M. Mellado Breakdown of academic impact, for papers by Marie Alix Peyrat Breakdown of academic impact, for papers by Gabriel Meister Breakdown of academic impact, for papers by Rosamund Chapman Breakdown of academic impact, for papers by Søren M. Madsen Breakdown of academic impact, for papers by R. Postlethwaite
Rankless by CCL
2026